Clinical Trials Logo

Soft Tissue Sarcoma, Child clinical trials

View clinical trials related to Soft Tissue Sarcoma, Child.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03056001 Completed - Clinical trials for Soft Tissue Sarcoma, Adult

Safety, Tolerability, and Efficacy of Doxorubicin and Pembrolizumab for Sarcoma

Start date: May 1, 2017
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability and efficacy of doxorubicin in combination with pembrolizumab in subjects with metastatic or unresectable soft tissue sarcoma. Based on previous studies, pembrolizumab may be an effective study treatment.